Skip to main content
Cardiogeni Plc logo

Cardiogeni Plc - Investor Relations & Filings

Listed IPO Apr 2026
ISIN · GB00BTBLFC12 LEI · 9845000F8F59ATZD8F92 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-07-09 Director's Dealing
Country GB United Kingdom
Listing Aquis Stock Exchange

Key figures FY2025

Period ended 2025-03-31 · GBP
Headline annual figures for Cardiogeni Plc, fiscal year 2025, reported in GBP, with the source filing for each figure.
Total Revenues GBP 7.75M per the Audit Report / Information filed 2025-10-24
Net Income GBP 1.02M per the Audit Report / Information filed 2025-10-24
Total Equity GBP 760.54k per the Audit Report / Information filed 2025-10-24

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Cardiogeni Plc

https://cardiogeni.com/

Cardiogeni Plc is a clinical-stage biotechnology company specializing in the development of regenerative medicines for the treatment of heart failure. Founded by Nobel Laureate Sir Martin Evans, the company focuses on creating novel therapies to address life-threatening cardiovascular diseases. Cardiogeni aims to become a market leader in heart failure regeneration by advancing its product pipeline, which includes candidates like heartcel, through clinical development and commercialization.

Recent filings

Filing Released Lang Actions
Grant of Incentive Options over Stock
Director's Dealing Classification · 100% confidence The document is an official announcement regarding the grant of incentive stock options to an Executive Director (Ajan Reginald). It includes a detailed table of the grant, the vesting period, and the total number of options held. It also includes the mandatory 'Notification and public disclosure of transactions by persons discharging managerial responsibilities' (PDMR) form, which is standard for director dealings. While it involves a director, the primary nature of the document is the disclosure of a transaction involving the company's own shares/options, which falls under the 'Director's Dealing' category.
2026-07-09 English
Director's Dealings
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by company directors (PDMRs) at Cardiogeni PLC. It follows the standard regulatory format for 'Notification and public disclosure of transactions by persons discharging managerial responsibilities', which is the definition for Director's Dealing (DIRS).
2026-07-07 English
Grant of Incentive Options over Stock
Director's Dealing Classification · 100% confidence The document is a formal notification of share option grants to company directors (PDMRs). It includes detailed tables of the transactions, specific names of the directors involved, and the required regulatory disclosure format for transactions by persons discharging managerial responsibilities. This falls squarely under the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions or option grants by company directors and executives.
2026-06-29 English
Repayment of Convertible Loan Notes
Capital/Financing Update Classification · 85% confidence The document is an RNS news release from Cardiogeni PLC announcing the full repayment of its Convertible Loan Notes (£810,000). This is an update on the company’s financing activities and a change in capital structure. It is not a financial report, dividend notice, or management change, but a capital/financing update.
2026-05-26 English
Update on Share Exchange Agreement
Capital/Financing Update Classification · 85% confidence The document is a short RNS announcement (under 5,000 characters) reporting the receipt of loan funding and completion of a Share Exchange Agreement. It is clearly an update on the company's fundraising and capital structure changes, which falls under the Capital/Financing Update category (CAP).
2026-04-29 English
TR-1: Standard notification of major holdings
Major Shareholding Notification Classification · 95% confidence The document is a TR-1 Standard Form for Notification of Major Holdings under the FCA/DTR rules, detailing shareholding percentages, threshold crossing date, and voting rights. This clearly corresponds to a major shareholding notification. According to the taxonomy, this maps to Major Shareholding Notification (Code: MRQ).
2026-04-27 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.